Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 67 Lung Neoplasms 29 Brain Neoplasms 11 Head and Neck Neoplasms 10 Neoplasms 9 Esophageal Neoplasms 9 Breast Neoplasms 8 Adenocarcinoma of Lung 8 Adenocarcinoma Of Esophagus 7 Glioblastoma 6 Gliosarcoma 5 Esophageal Squamous Cell Carcinoma 5 NSCLC 4 Central Nervous System Neoplasms 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Stomach Neoplasms 2 Osteosarcoma 2 Oligodendroglioma 2 Neuroblastoma 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Diseases 2 Glioma 2

Interventions

Cyclophosphamide 115 Dexamethasone 70 fludarabine phosphate 57 Cytarabine 56 fludarabine 52 Rituximab 51 Peripheral Blood Stem Cell Transplantation 40 Etoposide 40 Gemcitabine 39 Lenalidomide 38 pembrolizumab 33 Radiotherapy 33 Busulfan 33 Filgrastim 32 Carboplatin 31 Methotrexate 30 Cyclosporine 29 Cisplatin 29 Bortezomib 29 Mycophenolic Acid 28 Melphalan 28 venetoclax 27 Paclitaxel 26 Whole-Body Irradiation 24 Antilymphocyte Serum 23 Temozolomide 22 Granulocyte Colony-Stimulating Factor 20 Calcium Dobesilate 20 Bevacizumab 20 Tacrolimus 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Recurrence × Gefitinib × Clear all

NCT00824746 2013-02-26

ReGaiN

Chonnam National University Hospital

Phase 2 Completed

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡